March 28, 2020

SLE Patients Stake a Claim on Hydroxychloroquine Patients with systemic lupus erythematosus depend on hydroxychloroquine to control disease activity, but demand for this drug, which was already in short supply, has spiked since President Trump championed its use for COVID-19 patients. The American College of Rheumatology has responded by issuing a series of recommendations. Learn more in this article.

Telemedicine a Reality in Rheumatology During COVID-19 Pandemic Gauging joint inflammation via a computer monitor isn't ideal as these are determinations are best done in person, but due to the COVID-19 pandemic, the American College of Rheumatology is encouraging rheumatologists to embrace the technology as physicians increasingly limiting the number of in-office visits and as patients with autoimmune rheumatic disorders increasingly self-isolate.   Need a break from COVID-19 news? • RA Quiz: Have patient-reported outcomes improved over the years? • RA Quiz: Can you identify early rheumatoid arthritis? • RA Quiz: Which tests are better suited for diagnosing rheumatoid arthritis? • RA Quiz: How well does upadacitinib fare as RA treatment?   RHEUMATOLOGY HEALTHCARE JOB OPPORTUNITIES Visit Rheumatology Network for easy access to new job opportunities in rheumatology. As a service to our readers, we've posted a national "Job Board" in the upper right-hand corner of the site. Suggestions for other content sections? Email the editor at areyes@mmhgroup.com.